Saba Capital Management, L.P. bought HQL
May 10, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 57,862 shares of Abrdn Life Sciences Investors at $13.86 per share, a transaction worth $802.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
57,862
Price
$13.86
Total value
$802.0K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 10, 2024
Filing dateMay 14, 2024
Shares owned after3,215,825
OwnershipIndirect
10b5-1 planNo
AmendedNo